![]() |
市场调查报告书
商品编码
1626553
脱髮治疗产品市场:依产品类型、通路和地区,2024年至2031年Hair Loss Treatment Products Market By Product Type (Shampoo & Conditioner, Oil, Serum), Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Specialty Retailers, Pharmacies, Online Retail), & Region for 2024-2031 |
压力的增加、不良的饮食习惯、荷尔蒙失衡以及男性秃头的增加都导致了市场的成长。消费者越来越注重自己的外表和美丽。随着男性和女性越来越重视年轻化以及寻求解决头髮稀疏和秃头的有效解决方案,预计到2024年市场规模将达到 234亿美元,到2031年将达到 634亿美元。
雷射治疗和生髮精华等技术的进步以及非处方产品的日益普及推动市场扩张。此外,随着社群媒体和名人对护髮产品的代言推动了消费者兴趣的增加,脱髮治疗全球转变为一个蓬勃发展的行业,从2024年到2031年的年复合成长率约为 13.26%。
脱髮治疗产品市场:定义/概述
脱髮治疗产品包括药物、局部治疗、洗髮精、精华液、小工具等,目的是减缓、预防或逆转头髮稀疏或秃头。这些产品通常用于治疗雄性秃、荷尔蒙性脱髮和环境性脱髮。它因其用途而受到男性和女性的欢迎:促进头髮生长,强化现有头髮,并防止进一步脱髮。由于生物技术的进步、个人化治疗以及客户对非侵入性手术的需求不断增加,市场前景看好。预计干细胞疗法和促进毛髮生长配方等创新技术将在未来几年推动市场成长。
脱髮治疗市场中的全球雷射治疗部分迅速扩张,基于雷射的解决方案作为一种非侵入性治疗选择越来越受欢迎。根据2024年 2月的Market Watch 资料,雷射治疗市场预计将在2023年创造 31亿美元的收入,到2028年的年复合成长率为 15.6%。2024年1月,FDA核准了升级版家用雷射治疗设备,消费者接受度提升了92%。2024年 3月发表在 "International Journal of Trichology" 上的一项最新临床试验发现,低强度雷射疗法(LLLT)在六个月内成功使 85%的参与者的头髮重新长出来,并且该治疗对 25 至 45 岁之间的患者尤其有效。
2023年 12月,Philips计划推出一款突破性的人工智慧雷射治疗帽,临床试验证明,该治疗帽可以使头髮密度提高 67%。全球雷射设备领导者HairMax于2024年2月宣布,已与中国医疗保健公司BeiGene建立战略合作伙伴关係,以1.5亿美元的投资为后盾,在亚洲范围内提供最新的激光带技术。2024年3月,欧洲药品管理局(EMA)批准了一种将雷射治疗与生长因子结合的新型联合疗法;2024年4月,澳洲政府拨出7,500万澳元用于研究增强雷射技术用于头髮再生。此外,Venus Concept于2024年3月发布的季报显示,雷射设备销量较去年同期成长178%,显示消费市场扩张。
产品成本高且性能不稳定可能会严重阻碍掉髮治疗产品市场的扩张。许多治疗方法都很昂贵,尤其是那些需要处方或包括干细胞疗法等先进程序的治疗方法。这可能会限制其获得更大的消费者群体的机会,尤其是在可支配收入较低的新兴国家。此外,持续治疗带来的经济负担可能会阻止患者全力接受治疗,导致市场需求减少。例如,一些消费者可能愿意为成功的脱髮治疗付费,但结果的不确定性可能会使他们对支出持谨慎态度,特别是如果他们以前对无效的产品感到失望。
此外,脱髮治疗效果的差异可能会导致消费者的不信任和不满。市面上许多的药物,包括米诺地尔和非那雄胺等局部治疗药物,都不能保证对每个人都有效,导致使用体验各不相同。目前尚无针对所有类型脱髮的通用治疗方法,而且遗传、荷尔蒙和生活方式等变数都会影响个别治疗的效果,使问题更加复杂。这种差异会削弱市场信心,迫使潜在客户寻求替代疗法或完全避免治疗。因此,生产商面临的挑战不仅在于生产好的产品,还在于在消费者中建立声誉和信任。
Increasing stress, poor diet, hormonal imbalances, and an increase in occurrences of androgenetic alopecia are all contributing to the market's growth. Consumers are becoming more conscious of their personal grooming and aesthetics. With a greater emphasis on young appearance, both men and women are looking for effective ways to counteract hair thinning and balding is fuelling the USD 23.4 Billion in 2024 and reaching USD 63.4 Billion by 2031.
Technological improvements such as laser therapy and hair growth serums, together with increased availability of over-the-counter products, are driving market expansion. Furthermore, the influence of social media and celebrity endorsements of hair care products has raised consumer interest, transforming hair loss therapy into a thriving sector globally is grow at a CAGR of about 13.26% from 2024 to 2031.
Hair Loss Treatment Products Market: Definition/ Overview
Hair loss therapy goods include drugs, topical treatments, shampoos, serums, and gadgets that aim to delay, prevent, or reverse hair thinning and balding. These products are often used to treat androgenetic alopecia, hormonal hair loss, and environmental hair damage. Applications include increasing hair regrowth, strengthening existing hair, and preventing further hair loss, and are popular with both men and women. This market's future looks good, owing to advances in biotechnology, individualized treatments, and rising customer demand for non-invasive remedies. Innovations such as stem cell therapy and enhanced hair growth formulas are projected to fuel future market growth.
The global laser therapy segment of the hair loss treatment market is rapidly expanding, with laser-based solutions emerging as a popular non-invasive treatment option. According to Market Watch data from February 2024, the laser therapy market generated USD 3.1 Billion in 2023 and is expected to rise at a CAGR of 15.6% through 2028. In January 2024, the FDA approved upgraded at-home laser therapy equipment, which resulted in a 92% rise in consumer acceptance rates. In March 2024 Recent clinical trials published in the International Journal of Trichology found that low-level laser therapy (LLLT) resulted in successful hair regeneration in 85% of participants over a six-month period, with particular efficacy among patients aged 25-45.
Philips will released their groundbreaking AI-powered laser therapy hat in December 2023, with clinical testing showing a 67% improvement in hair density. HairMax, a world leader in laser devices, announced in February 2024 a strategic alliance with Chinese healthcare company BeiGene to deliver its latest laser band technology throughout Asia, backed by a USD 150 Million investment. In March 2024, the European Medicines Agency (EMA) approved a new combination therapy combining laser treatment with growth factors, while in April 2024 the Australian government set aside AUD 75 million for research into enhanced laser technology for hair restoration. Furthermore, Venus Concept's quarterly report in March 2024 disclosed a 178% rise in laser device sales compared to the previous year, demonstrating the expanding consumer
High product costs and uneven performance can seriously impede the expansion of the hair loss treatment products market. Many treatments, particularly those requiring a prescription or involving advanced therapies such as stem cell treatments, are expensive. This can limit access to a larger consumer base, especially in emerging economies with smaller disposable expenditures. Furthermore, the financial burden involved with continued therapies may prevent customers from pursuing remedies entirely, resulting in lower market demand. For example, while some consumers may be prepared to pay in successful hair loss solutions, uncertainty about the results may lead to caution in spending, especially for those who have previously encountered disappointment with less effective items.
Furthermore, the uneven efficacy of hair loss therapies might lead to consumer distrust and unhappiness. Many medicines on the market, including topical therapies like as minoxidil and finasteride, may not guarantee results for everyone, resulting in diverse user experiences. The lack of a common remedy for all types of hair loss complicates matters further, as individual therapy responses can vary depending on genetic, hormonal, and lifestyle variables. This discrepancy may lead to a loss of trust in the market, forcing potential clients to seek alternate cures or avoid therapy entirely. As a result, producers confront the problem of not only manufacturing good products but also building reputation and confidence among consumers.
Shampoos and conditioners are widely used in regular hair care routines, which might greatly boost the market for hair loss treatment solutions. As people become more aware of the importance of scalp health and hair maintenance, they are incorporating specialist hair care products that address hair loss into their regular routines. For example, manufacturers like as Nioxin and Kerastase are introducing shampoos and conditioners that are particularly designed to strengthen hair and stimulate growth while also addressing thinning hair concerns. In May 2024 L'Oreal launched plant-based hair care products to improve scalp health and meet the growing demand for eco-friendly choices. This emphasis on preventive care is causing more people to seek items that not only clean and condition hair but also contribute to overall hair health.
In April 2024, the FDA announced its support for clinical research on new formulations that combine traditional hair care products with active hair restoration chemicals, with the goal of increasing their effectiveness. This regulatory backing is anticipated to increase consumer trust in using these products on a regular basis, as they are intended not only for cosmetic appeal but also for genuine hair growth benefits.
However, the serum segment is the fastest expanding, owing to increased demand for focused therapies with greater efficacy and faster outcomes. Hair growth serums, which are frequently loaded with modern compounds such as peptides and minoxidil, are gaining popularity among consumers looking for more effective, non-invasive treatments for hair thinning and regrowth.
Rising sales through pharmacies are expected to greatly boost the hair loss treatment products industry. Pharmacies are increasingly becoming favored distribution channels for hair loss treatments due to their accessibility and consumers' trust in them for health-care items. The simplicity of purchasing hair loss remedies alongside other personal care items appeals to consumers looking for discreet and uncomplicated answers to their hair problems. Recent agreements between pharmaceutical firms and retail chains aim to increase the availability of popular therapies such as minoxidil and finasteride, allowing consumers to obtain effective remedies more easily. For instance, in June 2024, Walgreens announced a collaboration with numerous producers to ensure that popular hair loss remedies are more prominently advertised in their shops, thus catering to rising consumer demand.
In February 2024, the United States Department of Health initiated a campaign to educate the public on hair health, including the availability of treatments at local pharmacies. This campaign is aimed to raise awareness and encourage customers to seek out drugstore remedies for hair loss. With pharmacies serving as trustworthy sources of health information, this effort attempts to increase consumer confidence in purchasing hair loss remedies.
However, the fastest expanding area is online retail, which is driven by the convenience of home delivery, a larger selection of product offerings, and rising consumer preference for e-commerce platforms. Discounts, user reviews, and focused marketing all help online shops by attracting tech-savvy consumers looking for individualized hair loss solutions.
Country/Region-wise
The North American hair loss treatment products market is expanding rapidly, driven by rising demand for aesthetic treatments and increased awareness of innovative hair restoration options. According to latest market research data from March 2024, the market value hit USD 4.2 Billion in 2023 and is expected to increase at a CAGR of 9.8% between 2024 and 2028. This increase is most obvious in the United States, where roughly 50 million men and 30 million women suffer from hair loss, with 66% of males experiencing visible hair loss by the age of 35, according to the American Hair Loss Association's January 2024 report.
In August 2023, Johnson & Johnson's announced of their improved topical hair growth solution, which had an 85% success rate in clinical trials, and Merck received FDA clearance in February 2024 for a novel oral therapy for androgenetic alopecia. Additionally, in September 2023, the Canadian government announced a USD 50 Million investment in research funding for hair restoration technologies, with an emphasis on stem cell therapy and individualized treatment options. The advent of telemedicine services has also aided market growth, with companies such as Hims & Hers reporting a 120% increase in hair loss consultations in Q4 2023 over the previous year.
The Asia Pacific hair loss treatment products market is experiencing unprecedented expansion, driven by rising beauty consciousness and rising disposable income across the region. According to a Verified Market Research published the hair care market is predicted to rise at a CAGR of 5.60% to USD 129.63 Billion by 2031, from USD 83.83 Billion in 2023. China leads this expansion, accounting for 34% of the market, followed by Japan and South Korea. According to the Asian Dermatological Association's March 2024 report, 42% of men and 25% of women in metropolitan Asian areas suffer from premature hair loss, with a 73% increase in treatment-seeking behavior among people aged 25-40 over the last two years.
In February 2024, the Japanese government announced a historic USD 200 Million effort to promote research and development in hair restoration technology, while Singapore's Health Sciences Authority (HSA) gave fast-track approval status to three innovative hair loss therapies in March 2024. Alibaba, the Chinese e-commerce giant, reported that hair loss treatment product sales increased by 156% year on year during the 2024 Lunar New Year shopping festival, while Indian pharmaceutical company Sun Pharma announced in April 2024 that it would expand its hair care portfolio by acquiring a Korean hair technology startup for USD 180 Million.
The competitive landscape of the Hair Loss Treatment Products Market is characterized by the presence of various players offering a range of solutions, including prescription medications, over-the-counter treatments, and natural or herbal remedies. The market is increasingly driven by innovation, with companies focusing on developing new, advanced formulations like low-level laser therapy (LLLT) devices and stem cell treatments. Consumer preference for non-invasive and natural solutions is also shaping the market. Additionally, the rise of e-commerce platforms has intensified competition, as brands target a global audience through online sales channels, offering customized treatment plans and subscription-based services.
Some of the prominent players operating in the hair loss treatment products market Include:
L'Oreal
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer, Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs Ltd.
Ultrax Labs
Avalon Natural Products
Bayer
Pharma Medico
Kirkland Signature
Phyto Ales Group
Amplixin
Kerafiber
Keranique
DS Healthcare Group
Kaminomoto
Softto
Bawang
In July 2024, L'Oreal has launched a new plant-based, eco-friendly hair serum as part of its sustainability effort. The serum, which is part of the Kerastase line, targets early-stage hair thinning and is likely to appeal to environmentally aware consumers.
In June 2024, RepliCel announced development in its dermal sheath cup cell treatment for hair restoration. Early clinical data suggest enhanced hair follicle regeneration, and expanded trials are scheduled for late 2024.
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer, Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs Ltd.
Ultrax Labs
Avalon Natural Products
Bayer
Pharma Medico
Kirkland Signature
Phyto Ales Group
Amplixin
Kerafiber
Keranique
DS Healthcare Group
Kaminomoto
Softto
Bawang